XML 21 R8.htm IDEA: XBRL DOCUMENT v3.21.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Cash Flows From Operating Activities:    
Net income/(loss) $ 85,522 $ (908,995)
Adjustments to reconcile net income to net cash provided by operating activities:    
(Gains)/losses on residential whole loans and real estate owned, net (35,893) 217,920
(Gains)/losses on securities, net (100) 170,550
Impairment and other losses on securities available-for-sale and other assets 0 419,651
Accretion of purchase discounts on residential whole loans and securities (16,436) (12,114)
Amortization of purchase premiums on residential whole loans and securities, and amortization of terminated hedging instruments 6,791 15,266
(Reversal of provision)/provision for credit and valuation losses on residential whole loans and other financial instruments (23,967) 150,711
Net other non-cash losses included in net income 5,212 7,689
Increase in other assets (1,939) (37,811)
Increase/(decrease) in other liabilities 4,975 (9,653)
Net cash provided by operating activities 24,165 13,214
Cash Flows From Investing Activities:    
Purchases of residential whole loans, loan related investments and capitalized advances (184,707) (1,119,464)
Principal payments on residential whole loans and loan related investments 425,300 508,855
Principal payments on securities 58,896 539,882
Proceeds from sales of securities and other assets 0 1,009,316
Purchases of securities 0 (162,607)
Purchases of real estate owned and capital improvements (217) (5,606)
Proceeds from sales of real estate owned 50,619 52,042
Additions to leasehold improvements, furniture and fixtures (4,415) (176)
Net cash provided by investing activities 345,476 822,242
Cash Flows From Financing Activities:    
Principal payments on financing agreements with mark-to-market collateral provisions (821,716) (12,903,818)
Proceeds from borrowings under financing agreements with mark-to-market collateral provisions 663,926 12,216,862
Principal payments on other collateralized financing agreements (521,259) (37,418)
Proceeds from borrowings under other collateralized financing agreements 437,915 0
Payment made for other collateralized financing agreement related costs (1,371) 0
Principal payment on redemption of Senior notes (100,000) 0
Payments made for settlements and unwinds of Swaps 0 (88,405)
Proceeds from issuance of series C preferred stock 0 275,000
Payments made for costs related to series C preferred stock issuance 0 (8,912)
Proceeds from issuances of common stock 376 687
Payments made for the repurchase of common stock through the share repurchase program (20,933) 0
Dividends paid on preferred stock (8,219) 0
Dividends paid on common stock and dividend equivalents (34,015) (90,749)
Net cash used in financing activities (405,296) (636,753)
Net (decrease)/increase in cash, cash equivalents and restricted cash (35,655) 198,703
Cash, cash equivalents and restricted cash at beginning of period 821,519 134,664
Cash, cash equivalents and restricted cash at end of period 785,864 333,367
Supplemental Disclosure of Cash Flow Information    
Interest Paid 29,554 80,158
Non-cash Investing and Financing Activities:    
Transfer from residential whole loans to real estate owned 20,068 50,693
Dividends and dividend equivalents declared and unpaid 33,640 0
Payable for unsettled residential whole loan purchases 112,202 0
Receivable for unsettled residential whole loan and securities sales $ 0 $ 419,583